Immunological Definition of Acute Minimally Differentiated Myeloid Leukemia (MO) and Acute Undifferentiated Leukemia (AUL)

References

• Holowiecki J., Stella-Holowiecka B., Lutz D., Krzemien S., Callea V., Brugiatelli M., Schranz V., Ihle R., Keleny G., Jagoda K., Barceanu G., Lawniczek T. Diagnostic and prognostic value of immunological leukemia phenotyping. Lrtrkentias, Fleischer. Springer-Verlag, Berlin Heidelberg 1993; 47–52
   Google Scholar
• Ludwig W., Raghavachar A., Eckhard T. Immunophenotypic classification of acute lymphoblastic leukaemia. Bailliere's Clin. Hematol. 1994; 7: 235–262
   PubMed Web of Science ®Google Scholar
• Bain B., Catovsky D. Current concerns in hematology: classification of acute leukaemia. J. Clin. Pathol. 1990; 43: 882–887
   PubMed Web of Science ®Google Scholar
• van't Veer B. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Annals Hematol. 1992; 64: 161–165
   PubMed Web of Science ®Google Scholar
• Matutes E., Buccheri V., Morilla R., Shetty V., Dyer M., Catovsky D. Phenotypic heterogeneity in acute leukemias: immunological characterization and clinical relevance. Immunological, ultrastructural and molecular features of unclassifiable acute leukaemia in Recent Results in Cancer Research. Springer Verlag, Berlin 1992; 41–52, Heidelberg
   Google Scholar
• Heil G., Gunsilius E., Raghavachar A., Bartram C. R., Ganser A., Kurrle E., Aydemir U., Loffler H., Hoelzer D., Thiel E., Heimpel H. Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: Correlation to immunophenotype and treatment outcome. Blood 1991; 77: 1305–1312
   PubMed Web of Science ®Google Scholar
• Janossy G., Coustain-Smith E., Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 1989; 3: 170–181
   PubMed Web of Science ®Google Scholar
• Pombo deOliveira M., Matutes E., Rani S., Morilla R., Catovsky D. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukemia. Acta Haematologica 1988; 80: 61–64
   PubMed Web of Science ®Google Scholar
• Matutes E., Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature 8-cell disorders. Lark. Lymph. 1994; 13(1)11–14
   PubMed Web of Science ®Google Scholar
• Buccheri V., Mihaljevic B., Matutes E., Dyer M. J. S., Mason D. Y., Catovsky D. mb-1: a new marker forB-lineage lymphoblastic leukemia. Blood 1993; 82(3)853–857
   PubMed Web of Science ®Google Scholar
• Buccheri V., Shetty V., Yoshida N., Morilla R., Matutes E., Catovsky D. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia. A comparison with light and electron microscopy cytochemistry. Br. J. Hematol. 1992; 80: 62–68
   PubMed Web of Science ®Google Scholar
• Schoot Van Der E., Daams M., Pinkster J., Vet R., Borne Von Dem A. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br. J. Hematol. 1990; 74: 173–178
   PubMed Web of Science ®Google Scholar
• Musto P., Cascavilla N., Melillo L., Matera R., Carotenuto M. Clinical usefulness of immunocytochemical detection of myeloperoxidase in undifferentiated and biphenotypic acute leukemias. Haematologica. 1991; 76: 434–436
   PubMedGoogle Scholar
• Lee E. J., Pollak A., Leavitt R. D., Testa J. R., Schiffer C. A. Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood 1987; 70(5)1400–1406
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. 'R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br. J. Hematol. 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Praxedes Zimermnam M. K., de Oliveira L., Pereira Da Veiga W., Quintana I. Z., Tabak Pombo D. G., de Oliveira M. S. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia. Leuk. Lymph. 1994; 12: 233–239
   PubMed Web of Science ®Google Scholar
• Del Poeta G., Stasi R., Venditti A., Suppo G., Aronica G., Bruno A., Masi M., Tabilio A., Papa G. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994; 8(3)388–394
   PubMed Web of Science ®Google Scholar
• Stasi R. D., El Poeta G., Venditti A., Coppetelli U., Masi M., Cudillo L., Dentamaro T., Cox C., Adorno G., Papa G. Analysis of treatment failure in minimally differentiated acute myeloid leukemia (AML-MO). Proceedings of the XXVth International Society of Hematology. La revista de Investigacion clinica supplemento de abril, CancunUSA 1994; 270
   Google Scholar
• Alurkar S. S., Chopra H. K., Nair C. N., Zachariah L. V., Badrinath Y., Chougule A., Dhond S., Kumar K. A., Barbhayh S. A., Advani S. H. Minimally differentiated acute myeloid leukemia: a morphologic. cytochemical and ultrastructural study. Tumori 1992; 78: 185–189
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua A., Matutes E., Villamor N., Sierra J., Pujadea A., Reverter J. C., Feliu E., Cervantes Vives-F., Corrons J. L., Montserrat E and, Rozman C. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Br. J. Hematol. 1992; 81: 178–183
   PubMed Web of Science ®Google Scholar
• Solary E., Casasnovas R. O., Campos L., Bene M. C., Faure G., Maingon P., Falkenrodt A., Lenormand B., Genetet N. the Groupe d'Etude Immnunologique des Leucémies (GEIL)., Surface markers in adult acute myeloblastic leukemia: Correlation of CD 19+, CD34+ and CD14+/DR- phenotypes with shorter survival. Leukemia 1992; 6(5)393–399
   PubMed Web of Science ®Google Scholar
• Gassman W., Loffler H., Ludwig W. D., Sperling C., Thiel E., Uharek L., Freund M., Becher R., Donhuijsen-Ant R., Lengfelder E., Weh H. J., Aul C., Tirier C., Hagmann F. C., Fuhr H. G., Heil G., Kaboth W., Wandt H., Koch P., Hoelzer D., Sauerland Büchner Th. for the AML Cooperative Group. FAB classification of acute leukemias: high frequency of AML MO in German multicenter studies. Proceedings of the XIIth ISH-Meeting. Vienna 1993
   Google Scholar
• Scmpere A., Jarque I., Guinot M., Palau J., Garcia R., Sanz G. F., Gomis F., Perez-Sirvent M. L., Senent L., Sanz M. A. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): A study of eleven cases. Leuk. Lymph. 1993; 12: 103–108
   PubMed Web of Science ®Google Scholar
• Yokose N., Ogata K., Ito T., Miyake K., An E., Inokuchi K., Yamada T., Gomi S., Tanabe Y., Ohki I., Kuwabara T., Hasegawa S., Shinohara T., Dan K., Nomura T. Chemotherapy for minimally differentiated acute myeloid leukemia (AML-MO). A report on five cases and review of the literature. Annuls Hematol. 1993; 66: 61–70
   PubMedGoogle Scholar
• Bassan R., Biondi A., Benvestito S., Tini M. L., Abbate M., Viero P., Barbui T., Rambaldi A. Acute undifferentiated leukemia with CD7+ and CD 13+ immunophenotype. Cancer 1992; 69: 396–404
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Hirsch-Ginsberg C., Yee G., Huh Y., Freireich E., Stass S. Mixed lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 1990; 76: 808–813
   PubMed Web of Science ®Google Scholar
• Lo Coco F., De Rossi G., Pasqualetti D., Lopez M., Diverio D., Latagliata R., Fenu S., Mandelli F. CD7-positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br. J. Haematol. 1989; 73: 480–485
   PubMed Web of Science ®Google Scholar
• Nguyen D., Brynes R. K., Macaulay K., Kaplan Pinter-B., Brown L. C. Acute myeloid leukemia. FAM M-1 micro-granular variant: a multiparameter study. Hematol. Pathol. 1989; 3: 11–22
   PubMedGoogle Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffin J. D., Collins H., Nelson D. A., Bloomfield C. D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N. Engl. J. Med. 1987; 316(18)1111–1117
   PubMed Web of Science ®Google Scholar
• Campana D., Hansen-Hagge T. E., Matutes E., Coustan-Smith E., Yokota S., Shetty V., Bartram C. R., Janossy G. Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia. Leukemia 1990; 4(9)620–624
   PubMed Web of Science ®Google Scholar
• Asou N., Suzushima H., Hattori T., Nishikawa K., Wang J. X., Okubo T., Oura K., Sato M., Kawano F., Shido T., Takatsuki K. Acute unclassified leukemia originating from undifferentiated cells with the aberrant rearrangement and expression of immunoglobulin and T-cell receptor genes. Leukemia 1991; 5(4)293–299
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Pullon H., Layton D. M., Etches A., Huxtable A., Mangi M., Bellingham A. J., Mufti G. J. Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype. Br. J. Hematol. 1990; 76: 210–214
   PubMed Web of Science ®Google Scholar
• Heil G., Ganser A., Raghavachar A., Kurrle E., Heit W., Hoelzer D., Heimpel H. Induction of myeloperoxidase in five cases of acute unclassified leukaemia. Br. J. Hematol. 1988; 68: 23–32
   PubMed Web of Science ®Google Scholar
• Schoot Van Der E., Visser F. J., Tetteroo P. A. T., Von Dem Borne A. E. G. In-vitro differentiation of cells of patients with acute undifferentiated leukaemia. Br. J. Hematol. 1989; 71: 351–355
   PubMed Web of Science ®Google Scholar
• Ma W., Hu Z., Drexler H. G. Sensitivity of different methods for the detection of myeloperoxidase in leukemia cells. Leukemia 1994; 8: 336–342
   PubMed Web of Science ®Google Scholar
• Reuss-Borst M. A., Bühring H. J., Schmidt H., Müller C. A. AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8(2)258–263
   PubMed Web of Science ®Google Scholar
• Schwartz S., Bühring H. J., Busch F. W., Notter M., Bottcher S., Martin M., Thial E., Ludwig W. D. Differential expression of C-KIT protein product in hematopoietic malignancies. Annals Hematol. 1992; 65: A121
   PubMed Web of Science ®Google Scholar
• Siitonen T., Savolainen E. R., Koistinen P. Expression of the C-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994; 8(4)631–637
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Vincenzi C., Nadali G., Veneri D., Vinante F., Chilosi M., Basso G., Connelly M. C., Janossy G. Detection of membrane and intracellular antigens by flow cytometry following ORTHO Permeafix™ fixation. Leukemia 1994; 8(4)672–676
   PubMed Web of Science ®Google Scholar